The Cancer Letter

Inside information on cancer research and drug development

In Brief

Evanthia Galanis is the new group chair-elect of Alliance

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Evanthia Galanis was elected group chair-elect of the Alliance for Clinical Trials in Oncology at the 2023 Alliance Spring Virtual Group Meeting May 5. Galanis will take office in November 2023 and will serve a six-year term.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Congressional inaction harms federally funded oncology research and our patients:
The time for the cancer community to act is now

On behalf of the millions of Americans with cancer, whose very lives depend on our nation’s investment in oncology research, we ask that you join us now in urging congressional lawmakers to do the right thing: pass robust funding for the National Institutes of Health and the National Cancer Institute.
By Howard A. "Skip" Burris III, Charles D. Blanke, Monica M. Bertagnolli, Peter J. O'Dwyer, Mitchell D. Schnall, Douglas S. Hawkins, Quynh-Thu Le, Robert S. Mannel, Norman Wolmark and Janet Dancey
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account